Showing results (61-70 of 73) with videos related to

Sort By:
Pageof 8
Molecular Neurobiology|September 26, 2016
Pterostilbene Attenuates Early Brain Injury Following Subarachnoid Hemorrhage via Inhibition of the NLRP3 Inflammasome and Nox2-Related Oxidative StressHaixiao Liu, Lei Zhao, Liang Yue, et al.
Journal for Immunotherapy of Cancer|March 13, 2025
BTLA promoter hypomethylation correlates with enhanced immune cell infiltration, favorable prognosis, and immunotherapy response in melanomaMinglei Yang, Chenxi Zheng, Yu Miao, et al.
Blood|September 1, 2007
FTY720 demonstrates promising preclinical activity for chronic lymphocytic leukemia and lymphoblastic leukemia/lymphomaQing Liu, Xiaobin Zhao, Frank Frissora, et al.
Cancer Research|August 19, 2007
A potent indole-3-carbinol derived antitumor agent with pleiotropic effects on multiple signaling pathways in prostate cancer cellsJing-Ru Weng, Chen-Hsun Tsai, Samuel K Kulp, et al.
Oncology Reports|January 1, 2016
A method for establishing a patient-derived xenograft model to explore new therapeutic strategies for esophageal squamous cell carcinomaYanan Jiang, Qiong Wu, Xiawen Yang, et al.
British Journal of Haematology|April 8, 2011
OSU-DY7, a novel D-tyrosinol derivative, mediates cytotoxicity in chronic lymphocytic leukaemia and Burkitt lymphoma through p38 mitogen-activated protein kinase pathwayLi-Yuan Bai, Yihui Ma, Samuel K Kulp, et al.
Frontiers in Neurology|May 16, 2022
Comparison of Sex Differences in Outcomes of Patients With Aneurysmal Subarachnoid Hemorrhage: A Single-Center Retrospective StudyYuankun Cai, Zheng Liu, Chenguang Jia, et al.
International Journal of Surgery (London, England)|December 19, 2025
Integrated local and global Ki67 profiling for prognostic stratification and therapeutic guidance in high-grade neuroendocrine neoplasms: a multicenter validation studyJin Chu, Haiyu Gong, Heli Gao, et al.
Journal of Thoracic Disease|September 13, 2024
Neoadjuvant camrelizumab followed by concurrent camrelizumab plus chemotherapy for locally advanced esophageal squamous cell carcinoma: a single-arm, phase II studyYinliang Sheng, Xiangrui Meng, Chunyang Zhang, et al.
Hepatology (Baltimore, Md.)|March 11, 2011
Antitumor effects of OSU-2S, a nonimmunosuppressive analogue of FTY720, in hepatocellular carcinomaHany A Omar, Chih-Chien Chou, Lisa D Berman-Booty, et al.
Pageof 8